These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7625791)

  • 1. In vitro evaluation of the pneumocandin antifungal agent L-733560, a new water-soluble hybrid of L-705589 and L-731373.
    Bartizal K; Scott T; Abruzzo GK; Gill CJ; Pacholok C; Lynch L; Kropp H
    Antimicrob Agents Chemother; 1995 May; 39(5):1070-6. PubMed ID: 7625791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872).
    Bartizal K; Gill CJ; Abruzzo GK; Flattery AM; Kong L; Scott PM; Smith JG; Leighton CE; Bouffard A; Dropinski JF; Balkovec J
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2326-32. PubMed ID: 9371328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi.
    Tawara S; Ikeda F; Maki K; Morishita Y; Otomo K; Teratani N; Goto T; Tomishima M; Ohki H; Yamada A; Kawabata K; Takasugi H; Sakane K; Tanaka H; Matsumoto F; Kuwahara S
    Antimicrob Agents Chemother; 2000 Jan; 44(1):57-62. PubMed ID: 10602723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pneumocandin L-743,872 enhances the activities of amphotericin B and fluconazole against Cryptococcus neoformans in vitro.
    Franzot SP; Casadevall A
    Antimicrob Agents Chemother; 1997 Feb; 41(2):331-6. PubMed ID: 9021188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pneumocandins from Zalerion arboricola. IV. Biological evaluation of natural and semisynthetic pneumocandins for activity against Pneumocystis carinii and Candida species.
    Schmatz DM; Abruzzo G; Powles MA; McFadden DC; Balkovec JM; Black RM; Nollstadt K; Bartizal K
    J Antibiot (Tokyo); 1992 Dec; 45(12):1886-91. PubMed ID: 1490879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activities of semisynthetic pneumocandin L-733,560 against fluconazole-resistant and -susceptible Candida albicans isolates.
    Martinez-Suarez JV; Rodriguez-Tudela JL
    Antimicrob Agents Chemother; 1996 May; 40(5):1277-9. PubMed ID: 8723483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of A-192411.29, a novel antifungal lipopeptide.
    Nilius AM; Raney PM; Hensey-Rudloff DM; Wang W; Li Q; Flamm RK
    Antimicrob Agents Chemother; 2000 May; 44(5):1242-6. PubMed ID: 10770758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of a new pneumocandin antifungal agent, L-733,560 against azole-susceptible and -resistant Candida and Torulopsis species.
    Vazquez JA; Lynch M; Sobel JD
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2689-91. PubMed ID: 8593003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro antifungal activities and in vivo efficacies of 1,3-beta-D-glucan synthesis inhibitors L-671,329, L-646,991, tetrahydroechinocandin B, and L-687,781, a papulacandin.
    Bartizal K; Abruzzo G; Trainor C; Krupa D; Nollstadt K; Schmatz D; Schwartz R; Hammond M; Balkovec J; Vanmiddlesworth F
    Antimicrob Agents Chemother; 1992 Aug; 36(8):1648-57. PubMed ID: 1416847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of water-soluble pneumocandin analogs L-733560, L-705589, and L-731373 with mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis.
    Abruzzo GK; Flattery AM; Gill CJ; Kong L; Smith JG; Krupa D; Pikounis VB; Kropp H; Bartizal K
    Antimicrob Agents Chemother; 1995 May; 39(5):1077-81. PubMed ID: 7625792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the in vitro activities of the echinocandin LY303366, the pneumocandin MK-0991, and fluconazole against Candida species and Cryptococcus neoformans.
    Krishnarao TV; Galgiani JN
    Antimicrob Agents Chemother; 1997 Sep; 41(9):1957-60. PubMed ID: 9303393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro growth-inhibitory activity of pneumocandins L-733,560 and L-743,872 against putatively amphotericin B- and fluconazole-resistant Candida isolates: influence of assay conditions.
    Nelson PW; Lozano-Chiu M; Rex JH
    J Med Vet Mycol; 1997; 35(4):285-7. PubMed ID: 9292427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of a new semisynthetic echinocandin, LY-303366, against systemic isolates of Candida species, Cryptococcus neoformans, Blastomyces dermatitidis, and Aspergillus species.
    Zhanel GG; Karlowsky JA; Harding GA; Balko TV; Zelenitsky SA; Friesen M; Kabani A; Turik M; Hoban DJ
    Antimicrob Agents Chemother; 1997 Apr; 41(4):863-5. PubMed ID: 9087508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro antifungal activity of FK463, a new water-soluble echinocandin-like lipopeptide.
    Mikamo H; Sato Y; Tamaya T
    J Antimicrob Chemother; 2000 Sep; 46(3):485-7. PubMed ID: 10980180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro antifungal activity of a novel lipopeptide antifungal agent, FK463, against various fungal pathogens.
    Uchida K; Nishiyama Y; Yokota N; Yamaguchi H
    J Antibiot (Tokyo); 2000 Oct; 53(10):1175-81. PubMed ID: 11132964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of cilofungin, a lipopeptide antifungal agent, in vitro against fungi isolated from clinical specimens.
    Hanson LH; Stevens DA
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1391-2. PubMed ID: 2802565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New model of oropharyngeal and gastrointestinal colonization by Candida albicans in CD4+ T-cell-deficient mice for evaluation of antifungal agents.
    Flattery AM; Abruzzo GK; Gill CJ; Smith JG; Bartizal K
    Antimicrob Agents Chemother; 1996 Jul; 40(7):1604-9. PubMed ID: 8807048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifungal drug resistance in pathogenic fungi.
    Vanden Bossche H; Dromer F; Improvisi I; Lozano-Chiu M; Rex JH; Sanglard D
    Med Mycol; 1998; 36 Suppl 1():119-28. PubMed ID: 9988500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro antifungal activity of CAN-296: a naturally occurring complex carbohydrate.
    Ben-Josef AM; Manavathu EK; Platt D; Sobel JD
    J Antibiot (Tokyo); 1997 Nov; 50(11):937-43. PubMed ID: 9592567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of echinocandin-resistant mutants of Candida albicans: genetic, biochemical, and virulence studies.
    Kurtz MB; Abruzzo G; Flattery A; Bartizal K; Marrinan JA; Li W; Milligan J; Nollstadt K; Douglas CM
    Infect Immun; 1996 Aug; 64(8):3244-51. PubMed ID: 8757860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.